Cargando…
Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug Therapy
With 185 million people chronically infected globally, hepatitis C is a leading bloodborne infection. All-oral regimens of direct acting agents have superior efficacy compared to the historical interferon-based regimens and are significantly more tolerable. However, trials of both types of regimens...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
XIA & HE Publishing Inc.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075004/ https://www.ncbi.nlm.nih.gov/pubmed/27777889 http://dx.doi.org/10.14218/JCTH.2016.00017 |